[ad_1] The US Food and Drug Administration today approved a new drug, Arikayce (suspension of amikacin liposome inhalation), to treat a lung disease caused by a group of bacteria Mycobacterium avium complex …
Read More »[ad_1] The US Food and Drug Administration today approved a new drug, Arikayce (suspension of amikacin liposome inhalation), to treat a lung disease caused by a group of bacteria Mycobacterium avium complex …
Read More »